MetaInsight: an interactive web‐based tool for analyzing, interrogating, and visualizing network meta‐analyses using R‐shiny and netmeta RK Owen, N Bradbury, Y Xin, N Cooper, A Sutton Research synthesis methods 10 (4), 569-581, 2019 | 171 | 2019 |
Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network … Y Takaoka, T Suzuki, D Yoneoka, Y Nishikawa, WW San Tam, J Morze, ... Cochrane Database of Systematic Reviews, 2021 | 69 | 2021 |
Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic TJ Quinn, JK Burton, B Carter, N Cooper, K Dwan, R Field, SC Freeman, ... BMC medicine 19, 1-10, 2021 | 52 | 2021 |
Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis Y Xin, J Manson, L Govan, R Harbour, J Bennison, E Watson, O Wu BMC gastroenterology 16, 1-18, 2016 | 45 | 2016 |
Cost-effectiveness of HBV and HCV screening strategies–a systematic review of existing modelling techniques C Geue, O Wu, Y Xin, R Heggie, S Hutchinson, NK Martin, E Fenwick, ... PloS one 10 (12), e0145022, 2015 | 45 | 2015 |
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management … Y Xin, A Davies, A Briggs, L McCombie, CM Messow, E Grieve, WS Leslie, ... Diabetologia 63, 2112-2122, 2020 | 32 | 2020 |
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ... The lancet Diabetes & endocrinology 7 (3), 169-172, 2019 | 32 | 2019 |
Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis L Govan, O Wu, Y Xin, SJ Hutchinson, N Hawkins European journal of gastroenterology & hepatology 27 (8), 882-894, 2015 | 27 | 2015 |
Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight‐Plus weight management programme within a primary care randomized controlled trial Y Xin, A Davies, L McCombie, A Briggs, CM Messow, E Grieve, WS Leslie, ... Diabetic Medicine 36 (8), 1003-1012, 2019 | 25 | 2019 |
Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review CKH Wong, Q Liao, VYW Guo, Y Xin, CLK Lam Vaccine 35 (24), 3153-3161, 2017 | 24 | 2017 |
Effectiveness and cost-effectiveness of a loyalty scheme for physical activity behaviour change maintenance: results from a cluster randomised controlled trial RF Hunter, JM Murray, A Gough, J Tang, CC Patterson, DP French, ... international journal of behavioral nutrition and physical activity 15, 1-13, 2018 | 23 | 2018 |
Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson’s: a systematic review Y Xin, E McIntosh Quality of Life Research 26, 1-23, 2017 | 17 | 2017 |
Cost-effectiveness of the PDSAFE personalised physiotherapy intervention for fall prevention in Parkinson’s: an economic evaluation alongside a randomised controlled trial Y Xin, A Ashburn, RM Pickering, KC Seymour, S Hulbert, C Fitton, ... BMC neurology 20, 1-9, 2020 | 9 | 2020 |
Isolation, characterization and biological activity of a novel peptide from sika (Cervus nippon Temminck) antler FJ Huang, JX Ji, J Qian, KY Yang, Y Zhang, YQ Xin, ZG Jing, MH Wang, ... Pharmaceutical Biotechnology 2, 012, 2010 | 8 | 2010 |
A loyalty scheme to encourage physical activity in office workers: a cluster RCT R Hunter, A Gough, J Murray, J Tang, S Brennan, O Chrzanowski-Smith, ... Public Health Research 7 (15), 1-144, 2019 | 6 | 2019 |
Effectiveness and cost-effectiveness of a loyalty scheme for physical activity behaviour change maintenance: a cluster randomised controlled trial RF Hunter, JM Murray, A Gough, J Tang, C Patterson, DP French, ... The Lancet 392, S4, 2018 | 5 | 2018 |
From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R Y Xin, E Gray, JA Robles-Zurita, H Haghpanahan, R Heggie, ... Applied health economics and health policy, 1-10, 2022 | 4 | 2022 |
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis X Lu, ZY Zhou, Y Xin, MJ Wang, E Gray, V Jairath, JO Lindsay Inflammatory Bowel Diseases 30 (1), 64-77, 2024 | 3 | 2024 |
Feasibility study for interactive reporting of network meta-analysis: experiences from the development of the MetaInsight COVID-19 app for stakeholder exploration, re-analysis … Y Xin, CR Nevill, J Nevill, E Gray, NJ Cooper, N Bradbury, AJ Sutton BMC Medical Research Methodology 22 (1), 26, 2022 | 3 | 2022 |
Forget polypharmacy for type 2 diabetes! Weight management is a better investment M Lean, L McCombie, Y Xin Nephrology Dialysis Transplantation 37 (5), 844-846, 2022 | 2 | 2022 |